Malaysia is a Southeast Asian Multi-ethnic country with over 30 million population. The majority are ethnically Malay, with Indians, Chinese and indigenous peoples as minorities1. Lung cancer is one of the most common cancers and accounts for most of the cancer-related deaths in Malaysia2-4. The recent Malaysian National Cancer registry 2012-16 data show 78% of males & 81% of females of lung, trachea and bronchial cancer are diagnosed at stage 45. Lung cancer survival is poorest among all cancers with the 5-year observed survival rate of 9% and relative survival of 11%6. Screening and early diagnosis remain huge unmet needs. Limited awareness on lung cancer contributes to late stage presentation in most cases. The stigma around lung cancer as a 'self-inflicted' cancer together with fear and anxiety around chemotherapy, radiotherapy and cultural bias of complementary and traditional therapies are additional hurdles7.The Lung Cancer Network Malaysia (LCNM) and AstraZeneca are leading this digital initiative to focus on educating the primary care physicians on lung cancer.Learning ObjectivesThe initiative is based on the theme of "Conquering Lung Cancer Together" and aim to:
- Increase the awareness of lung cancer in HCPs, (especially general practitioners as patients/public most likely will first presented to them) in order to improve early detection for timely management of lung cancer.
- Improve the outcome of lung cancer management-to increase the chance of cure of the disease (early stage) and to improve patient's overall survival for advanced stage.
- Call to action: GP’s are able to detect and refer the suspected cases to the relevant specialty for timely diagnosis and treatment.
This CPD activity is presented by Dr. Hilmi Lockman, Assoc. Prof. Dr Tan Teik Hin, Dr. Anand Sachithanandan and Dr. Tho Lye Mun, and is supported by an educational grant from Astra Zeneca